Simvastatin treatment reduces the cholesterol content of membrane/lipid rafts, implicating the N -methyl-D-aspartate receptor in anxiety: a literature review. Brazilian Journal of Pharmaceutical Sciences, [S. l.], v. 53, n. 1, p. e16102-, 2017. DOI: 10.1590/s2175-97902017000116102. Disponível em: https://revistas.usp.br/bjps/article/view/131411.. Acesso em: 4 may. 2024.